Related Experiment Video
Updated: Oct 2, 2025

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
Published on: February 22, 2019
Non-Canonical Host Intracellular Niche Links to New Antimicrobial Resistance Mechanism
Michaela Kember1, Shannen Grandy1, Renee Raudonis1
1Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Abstract:
Globally, infectious diseases are one of the leading causes of death among people of all ages. The development of antimicrobials to treat infectious diseases has been one of the most significant advances in medical history. Alarmingly, antimicrobial resistance is a widespread phenomenon that will, without intervention, make currently treatable infections once again deadly. In an era of widespread antimicrobial resistance, there is a constant and pressing need to develop new antibacterial drugs. Unraveling the underlying resistance mechanisms is critical to fight this crisis. In this review, we summarize some emerging evidence of the non-canonical intracellular life cycle of two priority antimicrobial-resistant bacterial pathogens: Pseudomonas aeruginosa and Staphylococcus aureus. The bacterial factors that modulate this unique intracellular niche and its implications in contributing to resistance are discussed. We then briefly discuss some recent research that focused on the promises of boosting host immunity as a combination therapy with antimicrobials to eradicate these two particular pathogens. Finally, we summarize the importance of various strategies, including surveillance and vaccines, in mitigating the impacts of antimicrobial resistance in general.
Insights
Antimicrobial resistance is a growing threat. This review explores the intracellular life cycles of resistant bacteria like Pseudomonas aeruginosa and Staphylococcus aureus, and strategies to combat them.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Resistance
Background:
- Infectious diseases remain a leading cause of death globally.
- Antimicrobial resistance (AMR) poses a significant threat, potentially rendering current treatments ineffective.
- New antibacterial strategies are urgently needed to combat resistant pathogens.
Purpose of the Study:
- To review the non-canonical intracellular life cycle of *Pseudomonas aeruginosa* and *Staphylococcus aureus*.
- To discuss bacterial factors influencing intracellular survival and AMR.
- To explore host immunity boosting as a combination therapy and general AMR mitigation strategies.
Main Methods:
- Literature review of emerging evidence on bacterial intracellular life cycles.
- Analysis of bacterial factors contributing to resistance within intracellular niches.
- Summary of recent research on host-directed therapies and general AMR strategies.
Main Results:
- Emerging evidence highlights the non-canonical intracellular life cycle of *P. aeruginosa* and *S. aureus*.
- Bacterial factors within intracellular niches contribute to antimicrobial resistance.
- Host immunity boosting shows promise as a combination therapy.
Conclusions:
- Understanding bacterial intracellular survival is crucial for developing new antibacterial drugs.
- Combination therapies, including host-directed approaches, are vital for eradicating resistant pathogens.
- Broader strategies like surveillance and vaccines are essential for mitigating the impact of antimicrobial resistance.
Related Concept Videos
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Transduction
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antibiotic Selection
Intracellular Movement of Viruses and Bacteria

